rs199476128
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX1 | unassigned_transcript_4799 | c.577G>A | p.Val193Ile | missense_variant | Exon 1 of 1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|
Frequencies
GnomAD4 exome Cov.: 0
Mitomap
ClinVar
Submissions by phenotype
Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:1
- -
Mitochondrial disease Uncertain:1
The MT-COX1 m.6480G>A p.(Val193Ile) missense has been identified in individuals with a phenotype consistent with primary mitochondrial disease (Jaksch et al. 1998a; Jaksch et al. 1998b; Puomila et al. 2007; Cai et al. 2008). In several individuals, a second mitochondrial variant was also identified. The variant has also been reported in two of at least 851 controls, including in one individual who was homoplasmic (Jaksch et al. 1998a; Jaksch et al. 1998b; Cai et al. 2008; Dobrowolski et al. 2009; Ray et al. 2009). Based on the available evidence, the m.6480G>A variant is classified as a variant of uncertain significance for primary mitochondrial disease. -
Leigh syndrome Benign:1
The NC_012920.1:m.6480G>A (YP_003024028.1:p.Val193Ile) variant in MTCO1 gene is interpretated to be a Benign variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: BS1, BS4, BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at